Galera Therapeutics Inc (GRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GRTX | BMY | AMGN | GILD | VRTX |
| Company | Galera Therapeutics Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.1800 | 47.39 | 273.45 | 67.47 | 402.44 |
| High | 0.2100 | 47.50 | 274.35 | 67.90 | 403.88 |
| Low | 0.1760 | 44.37 | 267.24 | 65.09 | 393.00 |
| Last | 0.2075 | 44.70 | 269.38 | 65.27 | 397.70 |
| Change | +0.0248 | -4.16 | -3.63 | -1.81 | -3.06 |
| % Change | +13.57% | -8.51% | -1.33% | -2.70% | -0.76% |
| Volume | 647,153 | 44,973,228 | 1,758,986 | 13,934,312 | 787,217 |
| 20-Day Average Volume | 3,119,695 | 12,536,532 | 2,115,604 | 6,652,872 | 952,854 |
| Previous Close | 0.1827 | 48.86 | 273.01 | 67.08 | 400.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.1704 | 49.94 | 270.70 | 68.68 | 402.29 |
| 20-Day Raw Stochastic | 70.96% | 2.87% | 30.98% | 0.80% | 20.56% |
| 20-Day Relative Strength | 55.10% | 28.22% | 44.75% | 28.07% | 42.40% |
| Weighted Alpha | +2.92 | -34.83 | +9.08 | -23.91 | +14.69 |
| Today's Opinion | 8% Sell | 88% Sell | 72% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 24% Sell | 88% Sell | 40% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | Hold | 8% Sell | 24% Buy | 88% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.51% since 04/18/24 | -7.54% since 04/18/24 | +2.50% since 04/18/24 | -1.51% since 04/18/24 | +0.96% since 04/18/24 |
| Low | 0.1620 on 04/24/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 391.25 on 04/19/24 |
| High | 0.2100 on 04/25/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.78 on 04/25/24 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | -7.41% since 03/25/24 | -14.53% since 03/25/24 | -4.10% since 03/25/24 | -10.22% since 03/25/24 | -4.51% since 03/25/24 |
| Low | 0.1314 on 03/28/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 391.01 on 04/18/24 |
| High | 0.2385 on 04/17/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | +19.20% since 01/25/24 | -9.98% since 01/25/24 | -13.20% since 01/25/24 | -18.78% since 01/25/24 | -7.60% since 01/25/24 |
| Low | 0.1314 on 03/28/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 391.01 on 04/18/24 |
| High | 0.2900 on 02/28/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.51 on 01/26/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +11.09% since 10/25/23 | -21.11% since 10/25/23 | -1.04% since 10/25/23 | -16.88% since 10/25/23 | +9.43% since 10/25/23 |
| Low | 0.0853 on 10/31/23 | 44.37 on 04/25/24 | 249.70 on 10/31/23 | 65.09 on 04/25/24 | 341.90 on 11/16/23 |
| High | 0.2900 on 02/28/24 | 55.29 on 10/26/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 9,937 | 99,027,448 | 146,436,016 | 83,519,768 | 103,580,040 |
| Shares Outstanding, K | 54,392 | 2,026,759 | 536,376 | 1,245,077 | 258,459 |
| Annual Sales | 0 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -59,080,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 0 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -5,590,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 2.17 | 0.39 | 0.58 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 03/28/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/09/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.53 | 14.67 | 9.97 | 30.13 |